Overview

Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients

Status:
Unknown status

Trial end date:
2020-08-22

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of Thalidomide combined with R-CHOP(RT-CHOP) in newly diagnosed，untreated double-expressor Diffuse Large B-Cell Lymphoma patients (DLBCL)

Phase:

Phase 3

Details

Lead Sponsor:

Fudan University

Treatments:

Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Prednisone
Rituximab
Thalidomide
Vincristine